✦ LIBER ✦

Serum levels of fluconazole in patients after cytotoxic chemotherapy for hematological malignancy

✍ Scribed by Masahiro Kami; Yasufusa Sawada; Shin-ichiro Mori; Junji Hirate; Nakao Kojima; Yoshinobu Kanda; Akiko Moriya; Koichiro Yuji; Toshiki Saito; Shigeru Chiba; Hisamaru Hirai

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 60 KB
Volume: 66
Category: Article
ISSN: 0361-8609
DOI: 10.1002/1096-8652(200102)66:2<85::aid-ajh1022>3.0.co;2-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma concentration of itraconazole in

Plasma concentration of itraconazole in patients receiving chemotherapy for hematological malignancies: the effect of famotidine on the absorption of itraconazole

✍ Yoshinobu Kanda; Masahiro Kami; Tomohiro Matsuyama; Kinuko Mitani; Shigeru Chiba 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Fungal infection is a serious complication in immunocompromised patients, especially those with neutropenia. Itraconazole (ITZ) is expected to be an effective prophylactic agent for fungal infection because it has more activity against Aspergillus species than fluconazole and it is less toxic than a

Anti-T antibody in malignant melanoma pa

Anti-T antibody in malignant melanoma patients. Influence of response and survival following chemotherapy—changes in serum levels following C parvum, BCG immunization

✍ Dr. Nick Thatcher; Khalid Hashmi; James Chang; Ric Swindell; Derek Crowther 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB 👁 2 views

Prospective, concurrent comparison of th

Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignancies

✍ Jayesh Mehta; Ray Powles; Jennie Treleaven; Barbara Millar; Helen Proctor; Sandr 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

A prospective study was undertaken to compare the mononuclear cell, CD34+ cell, and CFU-GM yields of the Haemonetics MCS-3P and the Cobe Spectra cell separators in ten patients (nine multiple myeloma and one non-Hodgkin lymphoma) on two consecutive days after mobilization with high-dose filgrastim (